Navigation Links
AccuVein Receives Grant for its Award Winning AV300 Vein Illumination System
Date:11/4/2010

COLD SPRING HARBOR, N.Y., Nov. 4, 2010 /PRNewswire/ -- AccuVein LLC, the developer of the first non-contact, handheld vein illumination system, announced today that it had been awarded the maximum grant amount from the Qualifying Therapeutic Discover Project (QTDP) program.  This Federal grant program supports projects that show significant potential to produce new therapies, address unmet medical needs, and reduce the long-term growth of health care costs.

AccuVein's AV300 helps health care professionals locate veins for blood draw, IV infusion and blood donation by projecting a pattern of light on patient's skin that reveals the position of underlying veins.  This 10-ounce, hand-held device is available with a range of hands-free options so that it can quickly free the practitioner's hands to perform the venipuncture.  It is the first and only system of its kind.

"Hospitals are adopting vein visualization as the standard-of-care for venipuncture as a tool to reduce error, reduce cost and increase patient satisfaction," said AccuVein engineering vice president Joe Zott.  "Winning this grant will support our continued investment in delivering the best vein illumination system in the market."

About AccuVein

AccuVein LLC is a supplier of innovative, cutting-edge medical devices. The award winning AV300 allows health care providers to see a map of the position of peripheral veins on the skin's surface with the goal of helping to improve venipuncture procedures. Built using AccuVein's expertise in medical device miniaturization and user-intuitive design, the AV300 is the world's first portable, non-contact vein illumination solution. The AccuVein AV300 was the recipient of the 2010 Medical Design Excellence Award and was cited as a 2009 best new product in Contemporary Pediatrics Magazine.   AccuVein has filed applications for more than a dozen patents on the AV300's technology. It is in use at more than 400 U.S. hospitals and available for sale in over 50 countries. For more information on AccuVein's AV300, please visit www.accuvein.com.


'/>"/>
SOURCE AccuVein
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Fenwal Named Exclusive Provider of AccuVeins Award-Winning Vein Illumination Device for Blood and Plasma Centers
2. AccuVein Signs Exclusive Distribution Agreement in India to Sell Vein Illumination Device
3. AccuVein AV300 Named a Best New Product by Contemporary Pediatrics
4. AccuVein Signs Multiple-Country Distribution Agreement in Europe for Vein Illumination Device
5. Cocrystal Discovery Receives Awards for Its Novel Antiviral Drug Development Programs
6. DNA Medicine Institute Receives Qualifying Therapeutic Discovery Grant
7. Cardiogenesis Receives Research Award From Federal Government
8. BioMedixs TRAKnet Practice Management Software Receives ONC-ATCB 2011/2012 Certification
9. Pfizers Lyrica® (Pregabalin) Capsules CV Receives Approval for Treatment of Peripheral Neuropathic Pain In Japan
10. Roche Receives FDA Approval for a Second-Generation Hepatitis C Viral Load Test
11. BD Ranks Among Top 25 U.S. Companies in Newsweeks 2010 Green Rankings; Receives EPA Green Power Leadership Award; Named to Dow Jones Sustainability World Index for Fifth Consecutive Year
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... Genomic Health, Inc. (Nasdaq: GHDX ) today reported financial ... 31, 2015. --> --> Revenue ... $69.1 million in the fourth quarter of 2014, an increase of ... compared with the same period in the prior year. ... in the fourth quarter of 2015, an increase of 9 percent ...
(Date:2/10/2016)... HERTFORDSHIRE, England och ... -- Erbjudandet lämnas inte, och detta ... eller indirekt, i eller till, och inga ... uppdrag av aktieägare i, något land där ... av accept av Erbjudandet skulle strida mot ...
(Date:2/10/2016)... Mylan N.V. (NASDAQ, TASE: MYL) today announced ... December 31, 2015. --> --> ... revenues of $9.45 billion, up 28% on a constant ... of $9.43 billion. Excluding the impact of the acquisition ... generics business (the "EPD Business"), full year adjusted total ...
Breaking Medicine Technology:
(Date:2/11/2016)... ... 11, 2016 , ... Life is known for throwing curves. It’s thrown quite ... gather once a year to play softball to raise money through Sun Health ... than 50 players who competed in this year’s softball tournament share a history of ...
(Date:2/11/2016)... ... February 11, 2016 , ... ... their ongoing community involvement program, introduces a new charity campaign to raise funds ... are now being accepted at https://donate.rmhc.org/ . , Ronald McDonald House (RMH) ...
(Date:2/11/2016)... ... 2016 , ... From March 4 through 6, Hidrex ... at the Walter E. Washington Convention Center in Washington, D.C. , At the ... hyperhidrosis (excessive sweating) and its treatment options. Specifically, the company will be talking ...
(Date:2/11/2016)... Ore. (PRWEB) , ... February 11, 2016 , ... ... Medicaid coverage results in significantly higher rates of several common cancer screenings, especially ... resulting in better outcomes and survival rates. , The study,“What Does Medicaid ...
(Date:2/10/2016)... ... ... Early this week, Team Iconic at J. Walter Thompson and Nestlé KITKAT ... global confectionery brand sourced from 100% sustainable cocoa. , The Nestlé Cocoa Plan aims ... activities that focus on better farming, better lives and better cocoa. In order to ...
Breaking Medicine News(10 mins):